Use of thromboelastography in children on extracorporeal membrane oxygenation

J Pediatr Surg. 2022 Jun;57(6):1056-1061. doi: 10.1016/j.jpedsurg.2022.01.059. Epub 2022 Feb 14.

Abstract

Introduction: Extracorporeal membrane oxygenation (ECMO) profoundly impacts inflammatory and coagulation pathways, and strict monitoring is essential to guide therapeutic anticoagulation. Thromboelastography (TEG) offers a global evaluation of whole blood hemostatic system components and may be a valuable measurement of hemostatic function in these patients. There is a paucity of data correlating TEG parameters with standard measures of coagulation in heparinized pediatric patients.

Methods: Children on ECMO during a 10-year period were retrospectively reviewed. Standard measures of coagulation were matched to TEGs drawn within 30 min of each other.

Results: Out of 296 unique patients with 331 ECMO runs, 74.3% (n = 246) had at least one set of matched laboratory samples for a total of 2502 matched samples. The aPTT correlated with R-time (p<0.001). Platelets and fibrinogen correlated with α-angle (p<0.001). Fibrinogen (p<0.001) and platelets (p<0.001) were each associated with maximum amplitude (MA). 158 (47.7%) patients had at least one bleeding complication, and 100 (30.2%) had at least one thrombotic complication. Interestingly, a decreasing MA was associated with increased thrombotic complications (p<0.001).

Discussion: TEG correlated well with traditional measures of hemostasis in pediatric ECMO patients. However, there was not a clear benefit of the TEG over these other measures LEVEL OF EVIDENCE: III.

Keywords: Coagulation; Extracorporeal life support (ECLS); Extracorporeal membrane oxygenation (ECMO); Thromboelasography (TEG).

MeSH terms

  • Child
  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Fibrinogen
  • Hemostatics*
  • Humans
  • Retrospective Studies
  • Thrombelastography
  • Thrombosis*

Substances

  • Hemostatics
  • Fibrinogen